FDA Authorizes First Wearable Device to Continuously Monitor Glucose, Ketones
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The reporting (6)
- Abbott receives FDA nod for dual-analyte sensor MedTech Dive · 17d ago
- FDA issues novel nods for diabetes monitor, migraine lenses pharmaphorum · 17d ago
- FDA approves first wearable device to monitor glucose, ketone levels upi.com · 17d ago
- FDA authorizes Abbott's wearable to monitor ketone and glucose in diabetes patients Reuters · 17d ago
- Abbott receives FDA authorization for world's first dual glucose-ketone sensing technology for people with diabetes Abbott MediaRoom · 17d ago
- FDA Authorizes First Wearable Device to Continuously Monitor Glucose, Ketones Patient Care Online · 17d ago broke it first
Related trends
Charity founder says he secretly gave FTX fraud figure Caroline Ellison a job
A 501c3 charity has secretly hired former Alameda Research CEO Caroline Ellison, testing the crypto sector's redemption culture.
Court Strikes Down Trump Order to Keep an Aging Coal-Burning Plant Running
A federal court has blocked an order to keep an aging Michigan coal plant running, delivering a blow to revival efforts.
Why Cheap Used Cars Are So Hard to Find
Affordable pre-owned vehicles are increasingly difficult to locate as buyers chase low-cost inventory.
IEA warns of ‘lost period’ in global oil demand
Global oil demand faces a lost period as escalating conflicts and supply gaps push refining systems to the limit.
Oil, gas and borrowing costs surge as fears over Middle East escalate
Oil, gas, and borrowing costs surge as escalating Middle East tensions drive economic fears.
Nasdaq Invests in Kraken Parent Payward at $21 Billion Valuation
Nasdaq is investing $100 million in Kraken parent Payward at a $21 billion valuation to expand tokenized stocks.